Motif Bio
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 Skin Structures and Soft Tissue Infections | Phase 3 | 2015-11-01 |
| Completed | Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 Skin Structures and Soft Tissue Infections | Phase 3 | 2015-11-01 |